MicroRNAs in platelet physiology and function

Seminars in Thrombosis and Hemostasis

Volumn 42, Issue 3, 2016, Pages 215-222

  Lindsay, Cory R ^a   Edelstein, Leonard C ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

megakaryocytes; microparticles; microRNA; platelets

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; MESSENGER RNA; MICRORNA; MICRORNA 105; MICRORNA 142; MICRORNA 143; MICRORNA 146A; MICRORNA 146B; MICRORNA 150; MICRORNA 155; MICRORNA 22; MICRORNA 223; MICRORNA 34A; MICRORNA 486 3P; PADGEM PROTEIN; RNA BINDING PROTEIN; THROMBOPOIETIN; UNCLASSIFIED DRUG;

ARTICLE; CELL MATURATION; GENE EXPRESSION; HUMAN; MEGAKARYOCYTE; MEGAKARYOPOIESIS; NONHUMAN; PLATELET MICROPARTICLE; PRIORITY JOURNAL; RNA METABOLISM; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; CELL DIFFERENTIATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HEMOSTASIS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; THROMBOCYTOPOIESIS; THROMBOSIS;

BLOOD PLATELETS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; HEMOSTASIS; HUMANS; MEGAKARYOCYTES; MICRORNAS; RNA, MESSENGER; THROMBOPOIESIS; THROMBOSIS;

EID: 84975152249     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0035-1570077     Document Type: Article

References (82)

1. Hangauer M. J., Vaughn I. W., McManus M. T. Pervasive transcription of the human genome produces thousands of previously unidentified long intergenic noncoding RNAs. PLoS Genet: 2013; 9 6 e1003569
2. Cech T. R., Steitz J. A. The noncoding RNA revolution-trashing old rules to forge new ones. Cell: 2014; 157 1 77 94
3. Bray P. F., McKenzie S. E., Edelstein L. C., et al. The complex transcriptional landscape of the anucleate human platelet. BMC Genomics: 2013; 14 1
4. Teruel-Montoya R., Kong X., Abraham S., et al. MicroRNA expression differences in human hematopoietic cell lineages enable regulated transgene expression. PLoS ONE: 2014; 9 7 e102259
5. Weyrich A. S., Dixon D. A., Pabla R., et al. Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc Natl Acad Sci USA: 1998; 95 10 5556 5561
6. Denis M. M., Tolley N. D., Bunting M., et al. Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell: 2005; 122 3 379 391
7. Landry P., Plante I., Ouellet D. L., Perron M. P., Rousseau G., Provost P. Existence of a microRNA pathway in anucleate platelets. Nat Struct Mol Biol: 2009; 16 9 961 966
8. Bartel D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell: 2004; 116 2 281 297
9. Londin E., Loher P., Telonis A. G., et al. Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs. Proc Natl Acad Sci USA: 2015; 112 10 E1106 E1115
10. Friedman R. C., Farh K. K., Burge C. B., Bartel D. P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res: 2009; 19 1 92 105
11. Wienholds E., Kloosterman W. P., Miska E., et al. MicroRNA expression in zebrafish embryonic development. Science: 2005; 309 5732 310 311
12. Chen C., Ridzon D. A., Broomer A. J., et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res: 2005; 33 20 e179
13. Krol J., Loedige I., Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet: 2010; 11 9 597 610
14. Guo H., Ingolia N. T., Weissman J. S., Bartel D. P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature: 2010; 466 7308 835 840
15. Bazzini A. A., Lee M. T., Giraldez A. J. Ribosome profiling shows that miR-430 reduces translation before causing mRNA decay in zebrafish. Science: 2012; 336 6078 233 237
16. Djuranovic S., Nahvi A., Green R. miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science: 2012; 336 6078 237 240
17. Selbach M., Schwanhäusser B., Thierfelder N., Fang Z., Khanin R., Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature: 2008; 455 7209 58 63
18. Baek D., Villén J., Shin C., Camargo F. D., Gygi S. P., Bartel D. P. The impact of microRNAs on protein output. Nature: 2008; 455 7209 64 71
19. Schmiedel J. M., Klemm S. L., Zheng Y., et al. Gene expression. MicroRNA control of protein expression noise. Science: 2015; 348 6230 128 132
20. Alimonti A., Carracedo A., Clohessy J. G., et al. Subtle variations in Pten dose determine cancer susceptibility. Nat Genet: 2010; 42 5 454 458
21. Rigoutsos I., Tsirigos A. MicroRNA target prediction. In: Slack F. J., ed. MicroRNAs in Development and Cancer. Hackensack, NJ Imperial College Press: 2011; 237 264
22. Loeb G. B., Khan A. A., Canner D., et al. Transcriptome-wide miR-155 binding map reveals widespread noncanonical microRNA targeting. Mol Cell: 2012; 48 5 760 770
23. Edelstein L. C., McKenzie S. E., Shaw C., Holinstat M. A., Kunapuli S. P., Bray P. F. MicroRNAs in platelet production and activation. J Thromb Haemost: 2013; 11 01 340 350
24. Edelstein L. C., Bray P. F. Small RNAs as potential platelet therapeutics. Handb Exp Pharmacol: 2012; 210 435 445
25. Edelstein L. C., Bray P. F. MicroRNAs in platelet production and activation. Blood: 2011; 117 20 5289 5296
26. Zhai P. F., Wang F., Su R., et al. The regulatory roles of microRNA-146b-5p and its target platelet-derived growth factor receptor α (PDGFRA) in erythropoiesis and megakaryocytopoiesis. J Biol Chem: 2014; 289 33 22600 22613
27. Kamat V., Paluru P., Myint M., French D. L., Gadue P., Diamond S. L. MicroRNA screen of human embryonic stem cell differentiation reveals miR-105 as an enhancer of megakaryopoiesis from adult CD34+ cells. Stem Cells: 2014; 32 5 1337 1346
28. Chapnik E., Rivkin N., Mildner A., et al. miR-142 orchestrates a network of actin cytoskeleton regulators during megakaryopoiesis. eLife: 2014; 3 e01964
29. Metcalf D., Carpinelli M. R., Hyland C., et al. Anomalous megakaryocytopoiesis in mice with mutations in the c-Myb gene. Blood: 2005; 105 9 3480 3487
30. Bianchi E., Bulgarelli J., Ruberti S., et al. MYB controls erythroid versus megakaryocyte lineage fate decision through the miR-486-3p-mediated downregulation of MAF. Cell Death Differ: 2015; 22 12 1906 1921
31. Sportoletti P., Varasano E., Rossi R., et al. The human NPM1 mutation A perturbs megakaryopoiesis in a conditional mouse model. Blood: 2013; 121 17 3447 3458
32. Garzon R., Pichiorri F., Palumbo T., et al. MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci USA: 2015; 22 12 1906 1921
33. Wang Y., Huang R., Song C., Hu H., Zhang M. Some viral microRNAs were up-regulated in megakaryocytes incubated with immune thrombocytopenia plasma. Eur J Haematol: 2013; 90 3 220 227
34. Norfo R., Zini R., Pennucci V., et al. Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative Investigators. miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis. Blood: 2014; 124 13 e21 e32
35. Warshaw A. L., Laster L., Shulman N. R. The stimulation by thrombin of glucose oxidation in human platelets. J Clin Invest: 1966; 45 12 1923 1934
36. Weyrich A. S., Schwertz H., Kraiss L. W., Zimmerman G. A. Protein synthesis by platelets: historical and new perspectives. J Thromb Haemost: 2009; 7 2 241 246
37. Thon J. N., Devine D. V. Translation of glycoprotein IIIa in stored blood platelets. Transfusion: 2007; 47 12 2260 2270
38. Corduan A., Plé H., Laffont B., et al. Dissociation of SERPINE1 mRNA from the translational repressor proteins Ago2 and TIA-1 upon platelet activation. Thromb Haemost: 2015; 113 5 1046 1059
39. Londin E. R., Hatzimichael E., Loher P., et al. The human platelet: strong transcriptome correlations among individuals associate weakly with the platelet proteome. Biol Direct: 2014; 9 3
40. Edelstein L. C., Simon L. M., Montoya R. T., et al. Racial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR-376c. Nat Med: 2013; 19 12 1609 1616
41. Simon L. M., Edelstein L. C., Nagalla S., et al. Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics. Blood: 2014; 123 16 e37 e45
42. Kondkar A. A., Bray M. S., Leal S. M., et al. VAMP8/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA. J Thromb Haemost: 2010; 8 2 369 378
43. Nagalla S., Shaw C., Kong X., et al. Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity. Blood: 2011; 117 19 5189 5197
44. Mozaffarian D., Benjamin E. J., Go A. S., et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation: 2015; 131 4 e29 e322
45. Thomas K. L., Honeycutt E., Shaw L. K., Peterson E. D. Racial differences in long-term survival among patients with coronary artery disease. Am Heart J: 2010; 160 4 744 751
46. Bruchova H., Merkerova M., Prchal J. T. Aberrant expression of microRNA in polycythemia vera. Haematologica: 2008; 93 7 1009 1016
47. Xu X., Gnatenko D. V., Ju J., et al. Systematic analysis of microRNA fingerprints in thrombocythemic platelets using integrated platforms. Blood: 2012; 120 17 3575 3585
48. Elgheznawy A., Shi L., Hu J., et al. Dicer cleavage by calpain determines platelet microRNA levels and function in diabetes. Circ Res: 2015; 117 2 157 165
49. Stratz C., Nührenberg T., Fiebich B. L., et al. Controlled type II diabetes mellitus has no major influence on platelet micro-RNA expression. Results from micro-array profiling in a cohort of 60 patients. Thromb Haemost: 2014; 111 5 902 911
50. Leierseder S., Petzold T., Zhang L., Loyer X., Massberg S., Engelhardt S. MiR-223 is dispensable for platelet production and function in mice. Thromb Haemost: 2013; 110 6 1207 1214
51. Shi R., Ge L., Zhou X., et al. Decreased platelet miR-223 expression is associated with high on-clopidogrel platelet reactivity. Thromb Res: 2013; 131 6 508 513
52. Shrivastava M. The platelet storage lesion. Transfus Apheresis Sci: 2009; 41 2 105 113
53. Osman A., Hitzler W. E., Meyer C. U., et al. Effects of pathogen reduction systems on platelet microRNAs, mRNAs, activation, and function. Platelets: 2015; 26 2 154 163
54. Yu S., Deng G., Qian D., et al. Detection of apoptosis-associated microRNA in human apheresis platelets during storage by quantitative real-time polymerase chain reaction analysis. Blood Transfus: 2014; 12 4 541 547
55. Yu S., Huang H., Deng G., et al. miR-326 targets antiapoptotic Bcl-xL and mediates apoptosis in human platelets. PLoS ONE: 2015; 10 4 e0122784
56. Pontes T. B., Moreira-Nunes CdeF, Maués J. H., et al. The miRNA profile of platelets stored in a blood bank and its relation to cellular damage from storage. PLoS ONE: 2015; 10 6 e0129399
57. Kai Z. S., Pasquinelli A. E. MicroRNA assassins: factors that regulate the disappearance of miRNAs. Nat Struct Mol Biol: 2010; 17 1 5 10
58. Schöler N., Langer C., Döhner H., Buske C., Kuchenbauer F. Serum microRNAs as a novel class of biomarkers: a comprehensive review of the literature. Exp Hematol: 2010; 38 12 1126 1130
59. Lu J., Guo S., Ebert B. L., et al. MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Dev Cell: 2008; 14 6 843 853
60. Creemers E. E., Tijsen A. J., Pinto Y. M. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res: 2012; 110 3 483 495
61. Berckmans R. J., Nieuwland R., Böing A. N., Romijn F. P., Hack C. E., Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost: 2001; 85 4 639 646
62. Badrnya S., Baumgartner R., Assinger A. Smoking alters circulating plasma microvesicle pattern and microRNA signatures. Thromb Haemost: 2014; 112 1 128 136
63. Duan X., Zhan Q., Song B., et al. Detection of platelet microRNA expression in patients with diabetes mellitus with or without ischemic stroke. J Diabetes Complications: 2014; 28 5 705 710
64. Zampetaki A., Willeit P., Tilling L., et al. Prospective study on circulating MicroRNAs and risk of myocardial infarction. J Am Coll Cardiol: 2012; 60 4 290 299
65. Williams Z., Ben-Dov I. Z., Elias R., et al. Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations. Proc Natl Acad Sci USA: 2013; 110 11 4255 4260
66. Willeit P., Zampetaki A., Dudek K., et al. Circulating microRNAs as novel biomarkers for platelet activation. Circ Res: 2013; 112 4 595 600
67. Zhang Y-Y, Zhou X., Ji W-J., et al. Decreased circulating microRNA-223 level predicts high on-treatment platelet reactivity in patients with troponin-negative non-ST elevation acute coronary syndrome. J Thromb Thrombolysis: 2014; 38 1 65 72
68. Chyrchel B., Toton-Zuranska J., Kruszelnicka O., et al. Association of plasma miR-223 and platelet reactivity in patients with coronary artery disease on dual antiplatelet therapy: A preliminary report. Platelets: 2015; 26 6 593 597
69. de Boer H. C., van Solingen C., Prins J., et al. Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease. Eur Heart J: 2013; 34 44 3451 3457
70. Italiano J. E. Jr, Mairuhu A. T., Flaumenhaft R. Clinical relevance of microparticles from platelets and megakaryocytes. Curr Opin Hematol: 2010; 17 6 578 584
71. Hunter M. P., Ismail N., Zhang X., et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE: 2008; 3 11 e3694
72. Yuan A., Farber E. L., Rapoport A. L., et al. Transfer of microRNAs by embryonic stem cell microvesicles. PLoS ONE: 2009; 4 3 e4722
73. Risitano A., Beaulieu L. M., Vitseva O., Freedman J. E. Platelets and platelet-like particles mediate intercellular RNA transfer. Blood: 2012; 119 26 6288 6295
74. Gidlöf O., van der Brug M., Ohman J., et al. Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression. Blood: 2013; 121 19 3908 3917, S1-S26
75. Laffont B., Corduan A., Plé H., et al. Activated platelets can deliver mRNA regulatory Ago2•microRNA complexes to endothelial cells via microparticles. Blood: 2013; 122 2 253 261
76. Pan Y., Liang H., Liu H., et al. Platelet-secreted microRNA-223 promotes endothelial cell apoptosis induced by advanced glycation end products via targeting the insulin-like growth factor 1 receptor. J Immunol: 2014; 192 1 437 446
77. Duchez A. C., Boudreau L. H., Bollinger J., et al. Platelet microparticles are internalized in neutrophils via the concerted activity of 12-lipoxygenase and secreted phospholipase A2-IIA. Proc Natl Acad Sci USA: 2015; 112 27 E3564 E3573
78. Shan Z., Qin S., Li W., et al. An endocrine genetic signal between blood cells and vascular smooth muscle cells: role of microRNA-223 in smooth muscle function and atherogenesis. J Am Coll Cardiol: 2015; 65 23 2526 2537
79. Brogren H., Karlsson L., Andersson M., Wang L., Erlinge D., Jern S. Platelets synthesize large amounts of active plasminogen activator inhibitor 1. Blood: 2004; 104 13 3943 3948
80. Savini I., Catani M. V., Arnone R., et al. Translational control of the ascorbic acid transporter SVCT2 in human platelets. Free Radic Biol Med: 2007; 42 5 608 616
81. Evangelista V., Manarini S., Di Santo A., et al. De novo synthesis of cyclooxygenase-1 counteracts the suppression of platelet thromboxane biosynthesis by aspirin. Circ Res: 2006; 98 5 593 595
82. Schubert S., Weyrich A. S., Rowley J. W. A tour through the transcriptional landscape of platelets. Blood: 2014; 124 4 493 502